Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled Trial of Metformin for Antipsychotic-Induced Weight Gain in Patients with First-Episode Psychosis: A Pilot Study

Excessive weight gain and cardiometabolic dysfunction are common and clinically relevant side effects of antipsychotic medications. In this pilot study, we aimed to establish the feasibility of using metformin and its effectiveness in managing antipsychotic-induced weight gain in patients with first...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Charmaine, Chua, Yi Chian, Abdin, Edimansyah, Subramaniam, Mythily, Verma, Swapna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750805/
https://www.ncbi.nlm.nih.gov/pubmed/35010394
http://dx.doi.org/10.3390/ijerph19010137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750805/
https://www.ncbi.nlm.nih.gov/pubmed/35010394
http://dx.doi.org/10.3390/ijerph19010137

Ejemplares similares